Related references
Note: Only part of the references are listed.Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall
Kan Kajimoto et al.
ATHEROSCLEROSIS (2009)
Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
A. L. Chagas et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2009)
Metabolic Syndrome and Hepatocellular Carcinoma Two Growing Epidemics With a Potential Link
Abby B. Siegel et al.
CANCER (2009)
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
Nila Rafiq et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
NASH and HCC
John M. Page et al.
CLINICS IN LIVER DISEASE (2009)
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Curtis K. Argo et al.
CLINICS IN LIVER DISEASE (2009)
Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2009)
Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH
T. Ohki et al.
GUT (2009)
Differential Effects of JNK1 and JNK2 Inhibition on Murine Steatohepatitis and Insulin Resistance
Rajat Singh et al.
HEPATOLOGY (2009)
Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
Etsuko Hashimoto et al.
JOURNAL OF GASTROENTEROLOGY (2009)
The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology
Stephen Caldwell et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis
Paolo Sorrentino et al.
JOURNAL OF HEPATOLOGY (2009)
Iron in NASH, chronic liver diseases and HCC: How much iron is too much?
Antonello Pietrangelo
JOURNAL OF HEPATOLOGY (2009)
Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer
Qingshan Chang et al.
JOURNAL OF HEPATOLOGY (2009)
Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus
Ichiro Konishi et al.
LIVER INTERNATIONAL (2009)
Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients
Takamasa Ohki et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Diagnosis and therapy of nonalcoholic steatohepatitis
Dawn M. Torres et al.
GASTROENTEROLOGY (2008)
Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis
Pierre Nahon et al.
GASTROENTEROLOGY (2008)
Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease
Puneet Puri et al.
GASTROENTEROLOGY (2008)
Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation
Lijian Hui et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
Janus P. Ong et al.
JOURNAL OF HEPATOLOGY (2008)
Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
Asmaa Ibrahim Gomaa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Primary liver cancers with nonalcoholic steatohepatitis
Hiroaki Hashizume et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Deletion of NEMO/IKKγ in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma
Tom Luedde et al.
CANCER CELL (2007)
Two cases of non-alcoholic steatohepatitis with development of hepatocellular carcinoma without cirrhosis
Tatsuki Ichikawa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation
Toshiharu Sakurai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis
Hisanobu Ogata et al.
GASTROENTEROLOGY (2006)
Hepatocellular carcinoma arising from nonalcoholic steatohepatitis: Report of two cases
S Hai et al.
SURGERY TODAY (2006)
JNK1 but not JNK2 promotes the development of steatohepatitis in mice
JM Schattenberg et al.
HEPATOLOGY (2006)
Liver disease in patients with diabetes mellitus
SA Harrison
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
Hepatocellular carcinoma and nonalcoholic steatohepatitis developing during long-term administration of valproic acid
K Sato et al.
VIRCHOWS ARCHIV (2005)
EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer
A Huether et al.
BIOCHEMICAL PHARMACOLOGY (2005)
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease
M Hamaguchi et al.
ANNALS OF INTERNAL MEDICINE (2005)
Prevalence of and risk factors for fatty liver in a general population of Shanghai, China
JG Fan et al.
JOURNAL OF HEPATOLOGY (2005)
Effects of excess weight on cancer Incidences depending on cancer sites and histologic findings among men: Korea national health insurance corporation study
SW Oh et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study
G Bedogni et al.
HEPATOLOGY (2005)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia
ZR Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma
A Cuadrado et al.
OBESITY SURGERY (2005)
Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease
SR Weston et al.
HEPATOLOGY (2005)
Nonalcoholic fatty liver disease: A clinical review
DA Sass et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
LA Adams et al.
JOURNAL OF HEPATOLOGY (2005)
Chronological development of elevated aminotransferases in a nonalcoholic population
A Suzuki et al.
HEPATOLOGY (2005)
Hepatocellular carcinoma with nonalcoholic steatohepatitis
S Mori et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
KD Lindor et al.
HEPATOLOGY (2004)
Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis
E Bråkenhielm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
HB El-Serag et al.
GASTROENTEROLOGY (2004)
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
EE Calle et al.
NATURE REVIEWS CANCER (2004)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH
Y Yoshioka et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Obesity and hepatocellular carcinoma
SH Caldwell et al.
GASTROENTEROLOGY (2004)
Primary liver cancer:: Worldwide incidence and trends
FX Bosch et al.
GASTROENTEROLOGY (2004)
Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma
RE Bullock et al.
JOURNAL OF HEPATOLOGY (2004)
Hepatocellular carcinoma without cirrhosis in a patient with nonalcoholic steatohepatitis
R Bencheqroun et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2004)
Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C
JM Hui et al.
HEPATOLOGY (2003)
Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection
K Ohata et al.
CANCER (2003)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini et al.
HEPATOLOGY (2003)
NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States
JA Marrero et al.
HEPATOLOGY (2002)
A central role for JNK in obesity and insulin resistance
J Hirosumi et al.
NATURE (2002)
Adiponectin: a link between excess adiposity and associated comorbidities?
O Ukkola et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2002)
The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma
WW Hu et al.
CARCINOGENESIS (2002)
Fatty liver in non-alcoholic non-overweight Japanese adults: Incidence and clinical characteristics
K Omagari et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma
E Bugianesi et al.
GASTROENTEROLOGY (2002)
Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
M Shimada et al.
JOURNAL OF HEPATOLOGY (2002)
Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
S Nair et al.
HEPATOLOGY (2002)
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis
V Ratziu et al.
HEPATOLOGY (2002)
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
S Chitturi et al.
HEPATOLOGY (2002)
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association
G Pagano et al.
HEPATOLOGY (2002)
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease
J Ong et al.
LIVER TRANSPLANTATION (2001)
Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology
MM Skelly et al.
JOURNAL OF HEPATOLOGY (2001)
The role of diabetes in hepatocellular carcinoma: A case-control study among United States veterans
HB El-Serag et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2001)
Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial
S Kawata et al.
BRITISH JOURNAL OF CANCER (2001)
Hepatocellular carcinoma arising in non-alcoholic steatohepatitis
Y Zen et al.
PATHOLOGY INTERNATIONAL (2001)
A prospective study of obesity and cancer risk (Sweden)
A Wolk et al.
CANCER CAUSES & CONTROL (2001)
Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study
A Poonawala et al.
HEPATOLOGY (2000)
Role of diabetes mellitus in the etiology of hepatocellular carcinoma
P Lagiou et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Mitochondrial adaptations to obesity-related oxidant stress
SQ Yang et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Increased incidence of HFE C282Y mutations in patients, with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver
JF Blanc et al.
JOURNAL OF HEPATOLOGY (2000)
Share Paper
